ISGEDR Executive Committee Officers
Prof. Birgit Lorenz is currently Director and Chair of the Department of Ophthalmology of the Justus-Liebig-University and the Universitaetsklinikum Giessen and Marburg GmbH in Giessen, Germany. Attached to the department is a laboratory for Molecular Ophthalmology where a team of two full time scientists together with several doctoral fellows focus on the study of retinal degenerations including the development of animal models and novel gene therapeutic approaches. The department is a certified site for clinical studies of the European Vision Institute E.V.I.. Birgit Lorenz is professor of neuro-ophthalmology, pediatric ophthalmology and ophthalmic genetics. She qualified at the Ludwig-Maximilians-Universitaet of Munich and was a visiting scientist at the Institute of Ophthalmology, London, the Hospital for Sick Children, Great Ormond Street, London, and Moorfields Eye Hospital, London. She is a Fellow of the European Board of Ophthalmology (EBO), and Member of the Academia Ophthalmologica Internationalis (AOI) and the European Academy of Ophthalmology (EAO).
Prof. Lorenz was founding president of the European Paediatric Ophthalmological Society (EPOS), until 2010. She is founding leader of the section on Genetics of the German Ophthalmological Society (DOG). SheServes on the scientific advisory board of Pro Retina Germany. In 2011, she was elected member-at-large of the International Society of Genetic Eye Disease and Retinoblastoma ISGEDR.
Prof. Lorenz has edited 3 books and has published more than 280 peer-reviewed papers. Her research interests and research activities include genotyping and genotype-phenotype correlation of genetic eye diseases; gene therapy of hereditary retinal disorders; electrophysiology, psychophysics and imaging of hereditary eye diseases; wide-field-digital imaging and telemedicine for detection and quantification of acute retinopathy of prematurity, paediatric neuroophthalmology, pathophysiology of strabismus disorders, and pathophysiology of congenital and juvenile cataracts.
David Mackey is currently Professor of Ophthalmology at the Centre for Ophthalmology and Visual Science; University of Western Australia; and Managing Director of the Lions Eye Institute located in Perth, Western Australia
Professor David Mackey completed his medical degree with the University of Tasmania before training in Ophthalmology at the Royal Victorian Eye and Ear Hospital in Melbourne, Australia. He did fellowships in genetic eye diseases at the Royal Children’s Hospital in Melbourne, the Johns Hopkins Centre for Hereditary Eye Disease in Baltimore and Moorfields Eye Hospital in London.
He has spent 20 years studying the genetics of the optic nerve, with Leber Hereditary Optic Neuropathy the topic of his doctoral thesis. He conducted extensive studies into large pedigrees with Leber Hereditary Optic Neuropathy and Dominant Optic Atrophy. In 1993 he initiated the Glaucoma Inheritance Study in Tasmania (GIST), creating one of the largest glaucoma biobanks in the world, and is now recognised as an international leader in the genetics of glaucoma. In 2000 he started the Twins Eye Study in Tasmania and Brisbane to investigate the genetic and environmental factors contributing to the ocular biometry related to glaucoma and myopia. He also leads the Norfolk Island Eye Study, examining 800 descendants of the Bounty Mutineers, and in Western Australia runs the Raine Eye Health Study of 2,000 20-year olds from a birth cohort. He has over 200 publications across a wide range of genetic eye diseases.
In 1996 he was convener of the ISGEDR meeting in Tasmania.
Dr. Elias I. Traboulsi is the Head of the Department of Pediatric Ophthalmology and the Director of the Center for Genetic Eye Diseases at The Cleveland Clinic Cole Eye Institute. He is Professor of Ophthalmology at the Cleveland Clinic Lerner College of Medicine of Case University and Director of the Ophthalmology Residency Program at the Cleveland Clinic Foundation.
He also serves as Vice-Chairman for Education at the Cole Eye Institute and Chairman of the Department of Graduate Medical Education at the Cleveland Clinic. He is Past President of The International Society for Genetic Eye Diseases and Retinoblastoma and its current executive vice-president. He has been the Editor-In-Chief of Ophthalmic Genetics sine 1992. He has served on the editorial boards of the American Journal of Ophthalmology and the Journal of AAPOS. He currently serves on the boards of the Canadian Journal of Ophthalmology, the British Journal of Ophthalmology and the MEAJO. He has authored more than 400 scientific articles and book chapters. His book on “Genetic Diseases of the Eye” published by Oxford Univeristy Press in 1999 is one of the major references on this topic and its second edition was published in October 2011.
He has given 20 named Lectures and has visited and taught at numerous academic institutions around the world. He recently received the “Mater Educator” award at the Cleveland Clinic. Dr. Traboulsi’s clinical and research interests include the management and genetics of strabismus and congenital cataracts, and the nosology of ophthalmic and general medical genetic disorders and syndromes. He has special interest in ocular developmental biology and ocular malformations, retinal dystrophies, and connective tissue disorders, especially Marfan syndrome.
Dr. Brenda Gallie knows no boundaries when it comes to chasing the cure for retinoblastoma. As a practicing MD who has set up her own cancer research lab, she searches for earlier, better treatments of this hereditary eye cancer and saves the sight and lives of babies while providing insights into the nature of cancer.
Dr. Brenda Gallie wasn’t originally looking to find a cure for cancer. As a practicing ophthalmologist, her goal was to end suffering in the patients she saw by repairing diseased eyes. Then a rare from of hereditary cancer, which causes life-threatening tumors in infants, caught her eye. Retinoblastoma can rob a child of life by migrating up the optic nerve into the brain. And until Dr. Gallie turned her attention to the disease, the treatment could be even worse than the cancer, as radiation could set off new tumors in tiny bodies.
Dr. Alex Levin is Chief of the Wills Eye Pediatric Ophthalmology and Ocular Genetics Service. Dr. Levin graduated medical school from Jefferson Medical College, Thomas Jefferson University and completed a pediatric residency at the Children’s Hospital of Philadelphia (CHOP). After a year on staff at CHOP as a child abuse pediatrician, he then completed an ophthalmology residency program at Wills Eye Hospital and a fellowship in pediatric ophthalmology at The Hospital for Sick Children in Toronto. Dr. Levin is board certified in both pediatrics and ophthalmology and his interests include childhood cataract, childhood glaucoma, childhood uveitis, genetic eye disorders in adults and children, the eye in systemic diseases of childhood, child abuse, and medical and ophthalmology ethics. Dr. Levin is widely published in the pediatric and ophthalmology peer-reviewed literature and is frequently invited to speak at national and international conferences. He is a member of the American Academy of Pediatrics and American Academy of Ophthalmology.
Dr. Weleber specializes in genetics, retinal dystrophies. His research interests include retinitis pigmentosa and allied disorders, electrophysiology of the eye and visual system, congenital anomalies, dysmorphology, genetic and metabolic disease of the eye and visual system. Dr. Weleber currently sees patients with problems related to ophthalmic genetics and retinal dystrophies.